ydaU Antibody

Shipped with Ice Packs
In Stock

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Composition: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
ydaU antibody; b1359 antibody; JW1354 antibody; Uncharacterized protein YdaU antibody
Target Names
ydaU
Uniprot No.

Q&A

What is ydaU Antibody and how does it function in molecular detection systems?

ydaU Antibody is a rabbit polyclonal antibody specifically designed to recognize the uncharacterized ydaU protein from Escherichia coli (strain K12). This protein is also referred to as "Rac prophage; conserved protein" and is encoded by gene aliases including ydaU, ECK1357, and JW1354 .

The antibody functions through the same fundamental mechanisms as other research antibodies, utilizing specificity within the variable domains (Fv) formed by both heavy and light chains to selectively bind to its target antigen . While most therapeutic antibodies have well-characterized targets and mechanisms, research antibodies like ydaU Antibody are designed primarily for detection and characterization functions.

Methodological consideration for antigen-antibody interactions:
As with all antibodies, researchers should consider that binding efficacy is influenced by:

  • Proper folding of the antibody's antigen-binding regions

  • Epitope accessibility in the target protein

  • Buffer conditions affecting protein conformation

  • Sample preparation methods that preserve antigen integrity

What validation methods should be employed to confirm ydaU Antibody specificity?

Validation is critical for research reproducibility. For ydaU Antibody, multiple approaches should be implemented:

Table 1: Recommended Validation Methods for ydaU Antibody

Validation MethodProcedureExpected Result
Positive ControlTest against recombinant Escherichia coli (strain K12) ydaU proteinSpecific binding signal
Negative ControlTest against E. coli strain with ydaU knockoutNo binding signal
Western BlotRun samples with primary ydaU Antibody and appropriate secondary detectionSingle band at expected molecular weight
ELISA TitrationCreate dilution series (20-10,000 ng/mL)Linear dose-response in detection range
Cross-reactivity testTest against related bacterial proteinsNo significant binding to non-target proteins

Researchers should prepare validation data similar to standardized validation protocols used in other antibody systems. For example, Moreau et al. emphasized the importance of definitive markers when validating antibodies in different experimental systems .

What are the optimal experimental conditions for using ydaU Antibody in immunoassays?

Based on available technical data, the following conditions are recommended:

For ELISA applications:

  • Concentration range: 20-10,000 ng/mL

  • Buffer system: PBS with pH 7.4

  • Blocking agent: 1-5% BSA or non-fat milk

  • Detection: HRP-conjugated secondary antibody with appropriate substrate

For Western Blot applications:

  • Sample preparation: Standard denaturation with SDS and heat treatment

  • Blocking: 3-5% BSA or non-fat milk in TBST

  • Primary antibody incubation: Overnight at 4°C or 2 hours at room temperature

  • Secondary antibody: Anti-rabbit IgG conjugated to appropriate detection system

For both applications, researchers should perform titration experiments to determine optimal antibody concentration for their specific experimental system, as antibody performance can vary based on target concentration and sample complexity .

How should researchers address potential anti-drug antibody (ADA) interference when using ydaU Antibody?

While ydaU Antibody itself is not a therapeutic antibody, the principles of ADA interference apply to research contexts. Drug-interference challenges seen in therapeutic antibody detection systems provide valuable insights .

Addressing interference methodologically:

  • Acid dissociation technique: Similar to the ARIA (acid-dissociation radioimmunoassay) method, researchers can use acid treatment to dissociate potential interfering complexes .

  • Temperature-shift protocols: As demonstrated in therapeutic antibody detection, temperature-based dissociation (similar to TRIA methodology) can improve detection sensitivity .

  • Epitope blocking assessment: Determine if observed signals might be affected by competitive binding of other proteins to the target.

  • Serial dilution analysis: A non-linear dilution curve may indicate interference.

According to comparative studies of drug-tolerant assays, these approaches provide reasonably consistent views on antibody responses, though sensitivity may still vary at the lower detection range .

What are the key considerations for storage and handling of ydaU Antibody to maintain its functionality?

Proper storage and handling are critical for antibody performance and experimental reproducibility. For ydaU Antibody specifically:

Storage conditions:

  • Store at -20°C or -80°C upon receipt

  • Avoid repeated freeze-thaw cycles which can cause protein denaturation and loss of binding capacity

  • For long-term storage, maintain in lyophilized state at -20°C or lower

Handling recommendations:

  • Follow reconstitution protocols provided in the Certificate of Analysis

  • After reconstitution, store working aliquots to minimize freeze-thaw cycles

  • Use sterile techniques to prevent microbial contamination

  • Include preservative (e.g., 0.03% Proclin 300) for reconstituted solutions

These recommendations are consistent with general antibody handling protocols that preserve antibody structure and function, which directly impacts experimental reliability.

How can researchers optimize Western Blot protocols specifically for ydaU Antibody?

Western Blot optimization requires systematic adjustment of multiple parameters:

Table 2: Western Blot Optimization for ydaU Antibody

ParameterOptimization ApproachScientific Rationale
BlockingTest 3-5% BSA vs. non-fat milkDifferent blocking agents provide varying background reduction
Antibody dilutionTitrate from 1:500 to 1:5000Balances signal strength with background
Incubation timeCompare 1h room temp vs. overnight 4°CTemperature affects binding kinetics and equilibrium
Washing stringencyTest TBST with 0.05% vs. 0.1% Tween-20Detergent concentration affects non-specific binding removal
Detection systemCompare chemiluminescence vs. fluorescenceDifferent detection methods offer varying sensitivity and dynamic range

Researchers should conduct a systematic comparison of these parameters, similar to the methodological optimization approaches used in antibody-based detection systems described in immunogenicity studies .

What controls are essential when working with ydaU Antibody in different experimental systems?

Proper controls ensure experimental validity and interpretability:

Essential controls for ydaU Antibody experiments:

  • Positive control: Recombinant ydaU protein or E. coli K12 strain lysate known to express ydaU

  • Negative control: Lysate from ydaU knockout strain or unrelated bacterial species

  • Secondary antibody control: Omit primary antibody to assess non-specific binding

  • Isotype control: Non-specific rabbit IgG to assess potential non-specific interactions

  • Loading control: Antibody against constitutively expressed protein to normalize protein amounts

These control strategies parallel the approach recommended by Rodda and Moreau for studying B cell responses across different experimental systems , ensuring that observed signals represent genuine biological phenomena rather than technical artifacts.

How should researchers analyze data from ydaU Antibody experiments to ensure reliable quantification?

Data analysis from antibody-based experiments requires careful consideration of multiple factors:

For Western Blot quantification:

  • Use appropriate normalization to loading controls

  • Ensure linearity of signal within the analyzed range

  • Average results from multiple biological replicates

  • Consider both technical and biological variability in statistical analysis

For ELISA quantification:

  • Generate standard curves using purified recombinant ydaU protein

  • Ensure samples fall within the linear range of the standard curve

  • Use appropriate curve-fitting models (e.g., 4-parameter logistic)

  • Calculate coefficient of variation to assess precision

As suggested by studies on antibody quantification, results are most reliable when reported quantitatively rather than as simple positive/negative outcomes . This approach allows for more nuanced interpretation of experimental data.

What are advanced applications of ydaU Antibody beyond basic detection methods?

While ydaU Antibody is primarily used in ELISA and Western Blot applications, advanced research applications may include:

Immunoprecipitation (IP): Can be used to isolate ydaU protein and potential binding partners from complex samples, enabling:

  • Identification of protein-protein interactions

  • Characterization of protein complexes

  • Analysis of post-translational modifications

Immunofluorescence microscopy: May be used to study:

  • Subcellular localization of ydaU protein

  • Spatial-temporal expression patterns

  • Co-localization with other bacterial proteins

ChIP (Chromatin Immunoprecipitation): If ydaU has DNA-binding properties, ChIP could reveal:

  • DNA binding sites

  • Regulatory mechanisms

  • Gene expression control

These advanced applications require careful optimization but can provide deeper insights into protein function, similar to the multifaceted approaches used in modern antibody research described by Moreau et al.

How does ydaU Antibody compare to other research antibodies in terms of performance characteristics?

When evaluating ydaU Antibody against other research antibodies, several performance parameters should be considered:

Table 3: Comparative Performance Characteristics of Antibody Types

ParameterydaU Polyclonal AntibodyTypical Monoclonal AntibodiesImpact on Experimental Design
Epitope recognitionMultiple epitopesSingle epitopePolyclonals may provide more robust detection but less epitope specificity
Batch-to-batch variationModerate to highLowMonoclonals offer better reproducibility across experiments
SensitivityModerate to highVariable (epitope-dependent)Application-specific optimization required for both types
Cross-reactivityPotentially higherGenerally lowerValidation particularly important for polyclonals
Cost-effectivenessHigherLowerBudget considerations for repeated experiments

Understanding these differences helps researchers select the most appropriate antibody for their specific application and experimental system, following principles similar to those outlined in antibody design literature .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.